Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janna Berg

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 10, 2021
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive MarkersJanna Berg, Christina Ramberg, Jon Olav Sulheim Haugstvedt, et al.
BMC Cancer|July 15, 2018
Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary diseaseJanna Berg, Ann Rita Halvorsen, May-Bente Bengtson, et al.
Clinical & Translational Immunology|December 20, 2016
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary diseaseHanne Astrid Eide, Ann Rita Halvorsen, Vandana Sandhu, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 3, 2020
Lung cancer: Improved prognosis results in capacity challengesOdd Terje Brustugun, Sveinung Sørhaug, Bjørn Henning Grønberg, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 10, 2021
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive MarkersJanna Berg, Christina Ramberg, Jon Olav Sulheim Haugstvedt, et al.
BMC Cancer|July 15, 2018
Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary diseaseJanna Berg, Ann Rita Halvorsen, May-Bente Bengtson, et al.
Clinical & Translational Immunology|December 20, 2016
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary diseaseHanne Astrid Eide, Ann Rita Halvorsen, Vandana Sandhu, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 3, 2020
Lung cancer: Improved prognosis results in capacity challengesOdd Terje Brustugun, Sveinung Sørhaug, Bjørn Henning Grønberg, et al.
Pageof 2